Malaria in an asylum seeker paediatric liver transplant recipient: diagnostic challenges for migrant population

Serena Vita1, Simona Gabrielli2, Lucia Fontanelli Sulekova1

  • 1Migrant and global Health Research Organization (Mi-HeRO) Rome, Italy.

Insights

Transplant recipients face increased infection risks. This case highlights Plasmodium falciparum malaria in a pediatric liver transplant patient, emphasizing diagnostic challenges and drug interactions.

Area of Science:

  • Infectious Diseases
  • Transplantation Medicine
  • Tropical Medicine

Background:

  • Organ transplant recipients are immunocompromised, increasing susceptibility to infections.
  • Migration and transplant tourism contribute to the spread of geographically restricted pathogens.
  • Malaria is rare in transplant recipients but can occur via primary infection, reactivation, transfusion, or the transplanted organ.

Observation:

  • A two-year-old African boy, two years post-liver transplant, presented with Plasmodium falciparum infection.
  • The patient arrived at an Italian Asylum Seeker Center in May 2019.

Findings:

  • The case presented diagnostic challenges in a post-transplant malaria scenario.
  • Potential etiologies and drug interactions between immunosuppressants and antimalarials were analyzed.

Implications:

  • Highlights the need for vigilance regarding rare tropical infections in migrants.
  • Emphasizes careful evaluation of patients from endemic areas, even if infections are not local.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
102
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
256
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
76